Health Canada
- Status: approved
routine dose tacrolimus and less myfortic (routine dose tacrolimus and less myfortic) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Asan Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.